FMRO_MICOL
ID FMRO_MICOL Reviewed; 293 AA.
AC Q08325;
DT 01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT 24-JAN-2006, sequence version 2.
DT 03-AUG-2022, entry version 58.
DE RecName: Full=16S rRNA (guanine(1405)-N(7))-methyltransferase;
DE EC=2.1.1.179;
DE AltName: Full=16S rRNA m7G1405 methyltransferase;
DE AltName: Full=Fortimicin A-resistance methyltransferase;
GN Name=fmrO;
OS Micromonospora olivasterospora.
OC Bacteria; Actinobacteria; Micromonosporales; Micromonosporaceae;
OC Micromonospora.
OX NCBI_TaxID=1880;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND FUNCTION IN ANTIBIOTIC RESISTANCE.
RX PubMed=8486289; DOI=10.1016/0378-1119(93)90617-c;
RA Ohta T., Hasegawa M.;
RT "Analysis of the self-defense gene (fmrO) of a fortimicin A (astromicin)
RT producer, Micromonospora olivasterospora: comparison with other
RT aminoglycoside-resistance-encoding genes.";
RL Gene 127:63-69(1993).
RN [2]
RP SEQUENCE REVISION TO 189-208.
RA Ohta T., Hasegawa M.;
RL Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
CC -!- FUNCTION: Specifically methylates the N(7) position of guanine 1405 in
CC 16S rRNA (By similarity). Confers resistance to aminoglycosides.
CC {ECO:0000250, ECO:0000269|PubMed:8486289}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=guanosine(1405) in 16S rRNA + S-adenosyl-L-methionine = N(7)-
CC methylguanosine(1405) in 16S rRNA + S-adenosyl-L-homocysteine;
CC Xref=Rhea:RHEA:42772, Rhea:RHEA-COMP:10225, Rhea:RHEA-COMP:10226,
CC ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:74269,
CC ChEBI:CHEBI:74480; EC=2.1.1.179;
CC -!- MISCELLANEOUS: Protects M.olivasterospora, which is an antibiotic-
CC producing bacterium, against self-intoxication.
CC -!- SIMILARITY: Belongs to the methyltransferase superfamily.
CC Aminoglycoside resistance family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; D13171; BAA02451.2; -; Genomic_DNA.
DR AlphaFoldDB; Q08325; -.
DR SMR; Q08325; -.
DR BRENDA; 2.1.1.179; 12910.
DR GO; GO:0008649; F:rRNA methyltransferase activity; IEA:InterPro.
DR GO; GO:0046677; P:response to antibiotic; IEA:UniProtKB-KW.
DR Gene3D; 3.40.50.150; -; 1.
DR InterPro; IPR025981; rRNA_MeTrfase.
DR InterPro; IPR010769; rRNA_MeTrfase_GmN_bac.
DR InterPro; IPR029063; SAM-dependent_MTases_sf.
DR Pfam; PF07091; FmrO; 1.
DR PIRSF; PIRSF015852; RRNA_mtase_Grm; 1.
DR SUPFAM; SSF53335; SSF53335; 1.
PE 1: Evidence at protein level;
KW Antibiotic resistance; Methyltransferase; rRNA processing;
KW S-adenosyl-L-methionine; Transferase.
FT CHAIN 1..293
FT /note="16S rRNA (guanine(1405)-N(7))-methyltransferase"
FT /id="PRO_0000087316"
FT REGION 258..293
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT BINDING 47
FT /ligand="S-adenosyl-L-methionine"
FT /ligand_id="ChEBI:CHEBI:59789"
FT /evidence="ECO:0000250"
FT BINDING 80..82
FT /ligand="S-adenosyl-L-methionine"
FT /ligand_id="ChEBI:CHEBI:59789"
FT /evidence="ECO:0000250"
FT BINDING 86
FT /ligand="S-adenosyl-L-methionine"
FT /ligand_id="ChEBI:CHEBI:59789"
FT /evidence="ECO:0000250"
FT BINDING 111
FT /ligand="S-adenosyl-L-methionine"
FT /ligand_id="ChEBI:CHEBI:59789"
FT /evidence="ECO:0000250"
FT BINDING 134
FT /ligand="S-adenosyl-L-methionine"
FT /ligand_id="ChEBI:CHEBI:59789"
FT /evidence="ECO:0000250"
FT BINDING 160..161
FT /ligand="S-adenosyl-L-methionine"
FT /ligand_id="ChEBI:CHEBI:59789"
FT /evidence="ECO:0000250"
FT BINDING 176
FT /ligand="S-adenosyl-L-methionine"
FT /ligand_id="ChEBI:CHEBI:59789"
FT /evidence="ECO:0000250"
FT BINDING 185
FT /ligand="S-adenosyl-L-methionine"
FT /ligand_id="ChEBI:CHEBI:59789"
FT /evidence="ECO:0000250"
SQ SEQUENCE 293 AA; 30922 MW; 19D5E65F3B9E43D5 CRC64;
MLAAAKYRNL DPAFVERLAQ EAAERFRDRG QAVKYAKRKL HQAFGAFVAG TPAQAVAACV
AKIAAGAEPK EAGREAMRAH ASSAERVDWL EPFYERVAQW CGPASSVIDL ACGLNPLAVP
WMALAPGATY ACYDVDRTMA EALRALGTVY PVRVNAAAVD LVAAVPAAGV DVALVLKTLT
TVEQQRGGRR VAEYRRELTA VQHHSDGARS LSGRRGYADD PDAIVQRAVH GTGYEVVDEA
AFGTEALYHL VPLAGTAGRP APAEGAAEPG ATRPVVDVPA TARPDADRVD PTG